Celiprolol for the treatment of glaucoma

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424322, A61K 3117, A61K 3179

Patent

active

044709650

ABSTRACT:
An ophthalmic preparation for the treatment of glaucoma by the application to the glaucomatous eye of a celiprolol salt in a pharmaceutically acceptable ophthalmic carrier.

REFERENCES:
patent: 3930016 (1975-12-01), Berntsson et al.
patent: 4034009 (1977-07-01), Z/o/ lss et al.
patent: 4038313 (1977-07-01), Wilhelm
patent: 4120978 (1978-10-01), Wilhelm
patent: 4178374 (1979-12-01), Sweet
"Glaucoma Update"-Krieglstein et al.-editors-Springer-Verlag-New York-pp. 19-23 (1979)-Langham.
Chem. Abst. 71, 775(w) (1972)-Peori-Giraldi et al.
Arch. Ophthalmol. 95: 601-604 (1977)-Zimmerman et al.
Ophthalmalogica, Basel 184: 198-203 (1982)-Strempel.
Weiner Blinisch Wochenschrift, 90: 350-354 (1978)-Bonelli et al.
Pittner et al.: Celiprolol A Cardioselective Beta-Receptor Blocking Agent, (UL/2006/111, Chemie Linz AG Drug Division, 1982).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Celiprolol for the treatment of glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Celiprolol for the treatment of glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Celiprolol for the treatment of glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1194365

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.